Challenges and considerations faced in implementing HPV DNA testing as a primary screening tool
HPV DNA testing is shown to be significantly more effective compared to pap smear/cytology for cervical cancer screening. However, its implementation as a primary screening tool may not be as straightforward.
Join us in a 60-minute webinar delivered by speakers from Australia and Singapore on "Challenges and considerations faced in implementing HPV DNA testing as a primary screening tool".
Dr. Hawkes plays a key role in making Australia the first country in Asia-Pacific to implement HPV DNA testing as a primary screening tool for cervical cancer.
Practical tips to implement HPV DNA testing in your countries
Live Q&A session with the experts
Friday, 7 September 2018
13:45 – 14:45 (GMT+08:00)
10:45 – 11:45 (Karachi)
11:15 – 12:15 (Delhi)
12:45 – 13:45 (Bangkok / Ho Chi Minh / Jakarta)
13:45 – 14:45 (Hong Kong / Kuala Lumpur / Singapore)
14:45 – 15:45 (Seoul / Tokyo)
15:45 – 16:45 (Melbourne)